NEXLIZET and NEXLETOL are the only oral nonstatins FDA approved to lower bad cholesterol and reduce the risk* of the first or next serious heart event † in patients with statin intolerance. …

2024年9月26日 · This helps restore blood flow in adults with or at high risk of cardiovascular disease (CVD) who cannot take statins. The ezetimibe component reduces blood cholesterol by inhibiting the …

2025年4月4日 · Nexlizet (bempedoic acid/ezetimibe) is a prescription tablet used to reduce low-density lipoprotein (LDL) cholesterol in certain people. Learn about dosage, side effects, and more.

2024年6月30日 · Nexlizet reduces cholesterol by decreasing the amount made by your liver and increasing the breakdown of bad cholesterol. It also inhibits the absorption of cholesterol in the …

Indication NEXLIZET and NEXLETOL are indicated: bempedoic acid, a component of NEXLIZET and NEXLETOL, is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular …

Bempedoic acid, a component of NEXLIZET, is used: to lower the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, or heart procedures …

INDICATIONS AND USAGE NEXLIZET, a combination of bempedoic acid and ezetimibe, is indicated: • As an adjunct to diet, alone or in combination with other low-density lipoprotein cholesterol (LDL-C) …

2024年7月8日 · Nexlizet is a brand-name combination medication that treats adults with high cholesterol, including those with a genetic condition called familial hypercholesterolemia. For adults …

Overview Nexlizet is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic …

2025年5月27日 · Nexlizet (bempedoic acid/ezetimibe) is a prescription tablet used to help lower cholesterol and reduce the risk of heart attack as well as heart surgery. Nexlizet is prescribed for …